1. Home
  2. ADPT vs NNE Comparison

ADPT vs NNE Comparison

Compare ADPT & NNE Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • ADPT
  • NNE
  • Stock Information
  • Founded
  • ADPT 2009
  • NNE 2022
  • Country
  • ADPT United States
  • NNE United States
  • Employees
  • ADPT N/A
  • NNE N/A
  • Industry
  • ADPT Biotechnology: Biological Products (No Diagnostic Substances)
  • NNE
  • Sector
  • ADPT Health Care
  • NNE
  • Exchange
  • ADPT Nasdaq
  • NNE NYSE
  • Market Cap
  • ADPT 1.4B
  • NNE 1.2B
  • IPO Year
  • ADPT 2019
  • NNE 2024
  • Fundamental
  • Price
  • ADPT $10.38
  • NNE $37.31
  • Analyst Decision
  • ADPT Strong Buy
  • NNE Strong Buy
  • Analyst Count
  • ADPT 7
  • NNE 2
  • Target Price
  • ADPT $10.57
  • NNE $58.00
  • AVG Volume (30 Days)
  • ADPT 1.3M
  • NNE 5.5M
  • Earning Date
  • ADPT 07-31-2025
  • NNE 08-13-2025
  • Dividend Yield
  • ADPT N/A
  • NNE N/A
  • EPS Growth
  • ADPT N/A
  • NNE N/A
  • EPS
  • ADPT N/A
  • NNE N/A
  • Revenue
  • ADPT $189,527,000.00
  • NNE N/A
  • Revenue This Year
  • ADPT $24.46
  • NNE N/A
  • Revenue Next Year
  • ADPT $20.25
  • NNE N/A
  • P/E Ratio
  • ADPT N/A
  • NNE N/A
  • Revenue Growth
  • ADPT 8.61
  • NNE N/A
  • 52 Week Low
  • ADPT $2.99
  • NNE $6.30
  • 52 Week High
  • ADPT $10.87
  • NNE $48.05
  • Technical
  • Relative Strength Index (RSI)
  • ADPT 62.28
  • NNE N/A
  • Support Level
  • ADPT $9.90
  • NNE N/A
  • Resistance Level
  • ADPT $10.85
  • NNE N/A
  • Average True Range (ATR)
  • ADPT 0.48
  • NNE 0.00
  • MACD
  • ADPT -0.02
  • NNE 0.00
  • Stochastic Oscillator
  • ADPT 68.39
  • NNE 0.00

About ADPT Adaptive Biotechnologies Corporation

Adaptive Biotechnologies Corp is a company advancing the field of immune-driven medicine by harnessing the inherent biology of the adaptive immune system to transform the diagnosis and treatment of disease. Its clinical diagnostic product, clonoSEQ, is test authorized by the FDA for the detection and monitoring of minimal residual disease (MRD) in patients with multiple myeloma (MM), B cell acute lymphoblastic leukemia (ALL) and chronic lymphocytic leukemia (CLL) and is also available as a CLIA-validated laboratory developed test (LDT) for patients with other lymphoid cancers, including diffuse large B-cell lymphoma (DLBCL).

About NNE NANO NUCLEAR ENERGY INC

Nano Nuclear Energy Inc is an early-stage nuclear energy company developing smaller, cheaper, and safer portable clean energy solutions. It is focused on four business lines as part of development-Micro Nuclear Reactor Business is developing the next-generation nuclear microreactors, in particular ZEUS, a solid core battery reactor, and ODIN, a low-pressure salt coolant reactor; Fuel Processing Business; Fuel Fabrication Business; Fuel Transportation Business, and Nuclear Consultation Services.

Share on Social Networks: